Thrivent Financial for Lutherans Boosts Stock Holdings in Teleflex Incorporated $TFX

Thrivent Financial for Lutherans grew its position in Teleflex Incorporated (NYSE:TFX) by 1,161.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 550,449 shares of the medical technology company’s stock after acquiring an additional 506,796 shares during the quarter. Thrivent Financial for Lutherans owned about 1.25% of Teleflex worth $67,353,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the company. SYM FINANCIAL Corp acquired a new stake in Teleflex during the 3rd quarter worth $386,000. Summit Global Investments purchased a new stake in shares of Teleflex during the 3rd quarter valued at approximately $466,000. Annis Gardner Whiting Capital Advisors LLC raised its position in Teleflex by 23,100.0% in the third quarter. Annis Gardner Whiting Capital Advisors LLC now owns 696 shares of the medical technology company’s stock valued at $85,000 after purchasing an additional 693 shares during the period. Mirae Asset Global Investments Co. Ltd. purchased a new stake in Teleflex in the 3rd quarter valued at about $35,000. Finally, Federated Hermes Inc. raised its stake in shares of Teleflex by 11.0% in the 3rd quarter. Federated Hermes Inc. now owns 59,689 shares of the medical technology company’s stock valued at $7,304,000 after acquiring an additional 5,908 shares during the period. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

TFX has been the topic of several research analyst reports. Royal Bank Of Canada reiterated a “sector perform” rating and issued a $135.00 price objective on shares of Teleflex in a report on Wednesday, December 17th. Wall Street Zen cut shares of Teleflex from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a research report on Monday, December 29th. Needham & Company LLC upgraded shares of Teleflex from a “hold” rating to a “buy” rating and set a $138.00 target price for the company in a report on Tuesday, January 27th. Finally, Truist Financial upped their target price on Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a research report on Thursday, December 18th. Two analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $139.00.

Teleflex Stock Performance

NYSE:TFX opened at $104.40 on Monday. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.57 and a quick ratio of 1.53. The firm has a market cap of $4.61 billion, a price-to-earnings ratio of -14.20, a price-to-earnings-growth ratio of 1.36 and a beta of 0.92. The firm’s fifty day moving average price is $116.10 and its 200 day moving average price is $119.64. Teleflex Incorporated has a 1-year low of $100.18 and a 1-year high of $184.34.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, November 6th. The medical technology company reported $3.67 EPS for the quarter, topping the consensus estimate of $3.38 by $0.29. Teleflex had a negative net margin of 10.28% and a positive return on equity of 15.64%. The company had revenue of $892.90 million during the quarter, compared to analysts’ expectations of $892.79 million. During the same quarter last year, the business earned $3.49 EPS. The business’s revenue was up 19.4% on a year-over-year basis. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. On average, sell-side analysts expect that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, December 15th. Shareholders of record on Friday, November 14th were given a $0.34 dividend. The ex-dividend date was Friday, November 14th. This represents a $1.36 annualized dividend and a yield of 1.3%. Teleflex’s dividend payout ratio is presently -18.50%.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.